Milademetan (DS-3032) is a specific and orally active MDM2 inhibitor for the research of acute myeloid leukemia (AML) or solid tumors. Milademetan (DS-3032) induces G1 cell cycle arrest, senescence and apoptosis[1][2].
Molecular Weight:
618.53
Purity:
98.87
CAS Number:
[1398568-47-2]
Formula:
C30H34Cl2FN5O4
Target:
Apoptosis,E1/E2/E3 Enzyme,MDM-2/p53
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted